D47.02 – Systemic mastocytosis
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Type 1 Excludes
aggressive systemic mastocytosis (C96.21)
mast cell leukemia (C94.3-)
Applicable To
Indolent systemic mastocytosis
Isolated bone marrow mastocytosis
Smoldering systemic mastocytosis
Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
Code Also
, if applicable, any associated hematological non-mast cell lineage disease, such as:
acute myeloid leukemia (C92.6-, C92.A-)
chronic myelomonocytic leukemia (C93.1-)
essential thrombocytosis (D47.3)
hypereosinophilic syndrome (D72.1)
myelodysplastic syndrome (D46.9)
myeloproliferative syndrome (D47.1)
non-Hodgkin lymphoma (C82-C85)
plasma cell myeloma (C90.0-)
polycythemia vera (D45)
GEM Conversion to ICD-9 CM
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Sibling Codes
Parent Sibling Codes
View in Tabular
Code | Title |
---|---|
C00-D49 | Neoplasms (C00-D49) |
D37-D48 | Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48) |
D47 | Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
D47.0 | Mast cell neoplasms of uncertain behavior |
D47.02 |
Systemic mastocytosis
Type 1 Excludes
aggressive systemic mastocytosis (C96.21)
mast cell leukemia (C94.3-)
Applicable to
Indolent systemic mastocytosis
Isolated bone marrow mastocytosis
Smoldering systemic mastocytosis
Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
Code Also
, if applicable, any associated hematological non-mast cell lineage disease, such as:
acute myeloid leukemia (C92.6-, C92.A-)
chronic myelomonocytic leukemia (C93.1-)
essential thrombocytosis (D47.3)
hypereosinophilic syndrome (D72.1)
myelodysplastic syndrome (D46.9)
myeloproliferative syndrome (D47.1)
non-Hodgkin lymphoma (C82-C85)
plasma cell myeloma (C90.0-)
polycythemia vera (D45)
|